CAS 77-67-8
:Ethosuximide
Description:
Ethosuximide is an anticonvulsant medication primarily used in the treatment of absence seizures, particularly in children. It is classified as a succinimide derivative and works by inhibiting T-type calcium channels in the thalamic neurons, which helps to stabilize neuronal activity and reduce seizure frequency. Ethosuximide is typically administered orally and is known for its relatively favorable side effect profile compared to other antiepileptic drugs. Physically, it appears as a white to off-white crystalline powder, and it is soluble in water and organic solvents like ethanol. The chemical formula of ethosuximide is C7H11N1O2S, and it has a molecular weight of approximately 159.24 g/mol. Common side effects may include gastrointestinal disturbances, fatigue, and dizziness, but serious adverse reactions are rare. Regular monitoring is recommended to assess therapeutic levels and potential side effects, especially during the initial stages of treatment. Overall, ethosuximide is a well-established medication in the management of absence seizures, contributing significantly to the quality of life for affected individuals.
Formula:C7H11NO2
InChI:InChI=1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10)
InChI key:InChIKey=HAPOVYFOVVWLRS-UHFFFAOYSA-N
SMILES:C(C)C1(C)C(=O)NC(=O)C1
Synonyms:- 2,5-Pyrrolidinedione, 3-ethyl-3-methyl-
- 2-Ethyl-2-Methylsuccinimide
- 2-Methyl-2-ethylsuccinimide
- 3-Ethyl-3-methyl-2,5-pyrrolidinedione
- 3-Ethyl-3-methylpyrrolidine-2,5-dione
- 3-Ethyl-3-methylsuccinimide
- 3-Methyl-3-ethylpyrrolidine-2,5-dione
- 3-Methyl-3-ethylsuccinimide
- Atysmal
- Capitus
- Cn 10395
- Emeside
- Epileo Petitmal
- Ethosuxide
- Ethosuximid
- Ethosuximide [USAN:INN:BAN:JAN]
- Ethymal
- Etosuximid
- Etosuximida
- H 940
- Mesentol
- Nsc 64013
- Pemal
- Peptinimid
- Petinimid
- Petnidan
- Piknolepsin
- Pm 671
- Pyknolepsinum
- Ronton
- Simatin
- Succimal
- Succimitin
- Succinimide, 2-ethyl-2-methyl-
- Suxilep
- Suximal
- Suxinutin
- Zarodan
- Zarondan
- Zarondan-Saft
- Zarontin
- α-Ethyl-α-methylsuccinimide
- α-Methyl-α-ethyl-succinimide
- α-Methyl-α-ethylsuccinimide
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Ethosuximide
CAS:Formula:C7H11NO2Purity:>98.0%(GC)(T)Color and Shape:White to Almost white powder to crystalMolecular weight:141.17Ethosuximide
CAS:EthosuximideFormula:C7H11NO2Purity:100.0%Color and Shape:White SolidMolecular weight:141.07898Ethosuximide
CAS:Imides and their derivatives (excluding sacharin), and salts thereofFormula:C7H11NO2Color and Shape:White PowderMolecular weight:141.17 g/molEthosuximide
CAS:Ethosuximide (Zarontin) is an anticonvulsant, blocks the low voltage-activated T-type calcium channel used in the treatment of absence seizures unaccompanied byFormula:C7H11NO2Purity:98.87% - 99.97%Color and Shape:SolidMolecular weight:141.173-Ethyl-3-Methylpyrrolidine-2,5-Dione
CAS:3-Ethyl-3-Methylpyrrolidine-2,5-DioneFormula:C7H11NO2Purity:>98.0%Molecular weight:141.17Ethosuximide
CAS:Formula:C7H11NO2Purity:≥ 98.0%Color and Shape:White to almost white powder or crystalsMolecular weight:141.17Ethosuximide
CAS:Controlled ProductEthosuximide is a drug used as a treatment for epileptic seizures, which is chemically related to valproic acid. Ethosuximide has been shown to inhibit the production of DNA from streptococcal pharyngitis, which may be due to its ability to bind to the α1 subunit of DNA polymerase. It also inhibits the synthesis of protein in experimental models and human serum. Ethosuximide has long-term efficacy in animal studies and is well tolerated at low doses.Formula:C7H11NO2Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:141.17 g/molEthosuximide
CAS:3-Ethyl-3-methylpyrrolidine-2,5-dioneFormula:C7H11NO2Purity:98%Molecular weight:141.17
